Safety Outcomes of First-Line Venetoclax vs Second-Generation BTKi in CLL/SLL: A Retrospective Cohort Study

Blood Neoplasia · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles